News
Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 ...
This webinar offers essential tools and insights to help organisations confidently navigate the BioSecure Act, ensuring they ...
Amid a push to phase out animal testing, Charles River’s Steve Bulera notes that the implementation of alternative methods ...
Madrigal Pharmaceuticals’ Rezdiffra has been approved in Europe for the treatment of MASH with moderate to advanced liver ...
Global orphan drug sales are on the rise. To dodge potential pitfalls associated with reaching ultra-rare populations, ...
Before Novo arrived as its owner, issues at the Bloomington facility caused a two-month delay for Eylea HD’s FDA approval ...
Gilead will integrate Interius, the first biotech to push an in vivo CAR-T therapy into the clinic, into its cell therapy ...
In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...
Santen has signed an agreement with RemeGen for the RC28-E intravitreal injection, a dual-target fusion protein for retinal ...
The FDA has granted approval for Ionis Pharmaceuticals’ Dawnzera (donidalorsen), for use in preventing hereditary angioedema ...
Biotechnology company āshibio has entered an exclusive licensing agreement with Mereo BioPharma for the monoclonal antibody, ...
Bavarian Nordic bolstered its cash reserves with a $160m sale of a priority review voucher in June 2025. The company has now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results